Brightintel Bioscience

Brightintel Bioscience (Suzhou) Co., Ltd. was founded in 2022 as a high-tech enterprise specializing in biopharmaceuticals and AI-driven drug research and development. The company is committed to advancing new drug discovery through innovative technologies, establishing an integrated service system encompassing 'technology R&D, product development, and market promotion.' Adhering to the business philosophy of 'innovation-driven and win-win cooperation,' Brightintel Bioscience aims to become a globally leading brand in biopharmaceuticals and AI-powered drug R&D.